FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079585105> ?p ?o ?g. }

• W2079585105 endingPage "1146" @default.
• W2079585105 startingPage "1140" @default.
• W2079585105 abstract "In Brief Objective: We analyzed use of venous thromboembolism (VTE) prophylaxis in patients undergoing oncologic surgery and examined the influence of surgeon and hospital characteristics on prophylaxis. Background: Cancer patients undergoing surgery are at high-risk for VTE. Despite the risk of VTE, the use of prophylaxis is variable. Little is known about the patient, surgeon, and hospital characteristics that influence the use of prophylaxis. Methods: Patients undergoing oncologic surgery from 2003 to 2007 and recorded in the Perspective database were analyzed. Surgeons and hospitals were stratified into volume-based tertiles for analysis. The effects of surgeon and hospital volume on use of any prophylaxis and pharmacologic prophylaxis were examined using generalized estimating equations adjusted for confounding variables. Results: In the cohort of 252,950 patients, some form of prophylaxis was given to 79% of patients whereas 46% received pharmacologic prophylaxis. The rate of VTE prophylaxis was 82.7% at high-volume hospitals compared with 75.6% at low-volume facilities (P < 0.0001). After adjustment for case mix and surgeon volume, the odds ratio for receipt of prophylaxis at high- versus low-volume hospitals was 1.40 (95% CI, 1.20–163). The odds ratio for prophylaxis for patients treated by high-volume surgeons was 1.35 (95% CI, 1.14–160) after adjusting for case mix and hospital volume. The rate of pharmacologic VTE prophylaxis was 53.1% in high-volume hospitals versus 38.8% in low-volume hospitals (P < 0.0001). Treatment at a high-volume hospital was associated with an odds ratio of 1.42 (95% CI, 1.22–1.66) for pharmacologic prophylaxis whereas the odds ratio for pharmacologic prophylaxis for patients treated by high-volume surgeons was 1.28 (95% CI, 1.08–1.51). Conclusion: VTE prophylaxis is underutilized in patients undergoing oncologic surgery. Patients treated by high-volume surgeons and at high-volume hospitals are more likely to receive appropriate prophylaxis. Venous thromboembolism prophylaxis is underutilized in patients undergoing oncologic surgery. Patients treated by high-volume surgeons and at high-volume hospitals are more likely to receive appropriate prophylaxis." @default.
• W2079585105 created "2016-06-24" @default.
• W2079585105 creator A5008763534 @default.
• W2079585105 creator A5028295343 @default.
• W2079585105 creator A5033931830 @default.
• W2079585105 creator A5039100454 @default.
• W2079585105 creator A5057686070 @default.
• W2079585105 creator A5079072671 @default.
• W2079585105 creator A5079268091 @default.
• W2079585105 date "2011-06-01" @default.
• W2079585105 modified "2023-10-12" @default.
• W2079585105 title "Quality of Venous Thromboembolism Prophylaxis in Patients Undergoing Oncologic Surgery" @default.
• W2079585105 cites W1968339106 @default.
• W2079585105 cites W1968389730 @default.
• W2079585105 cites W1970009268 @default.
• W2079585105 cites W1980221743 @default.
• W2079585105 cites W1985164328 @default.
• W2079585105 cites W1994609390 @default.
• W2079585105 cites W2000445173 @default.
• W2079585105 cites W2000742360 @default.
• W2079585105 cites W2010599049 @default.
• W2079585105 cites W2017184077 @default.
• W2079585105 cites W2022713742 @default.
• W2079585105 cites W2022932023 @default.
• W2079585105 cites W2023603983 @default.
• W2079585105 cites W2046133119 @default.
• W2079585105 cites W2062494466 @default.
• W2079585105 cites W2089799164 @default.
• W2079585105 cites W2091716109 @default.
• W2079585105 cites W2101383237 @default.
• W2079585105 cites W2109113725 @default.
• W2079585105 cites W2112238954 @default.
• W2079585105 cites W2124784637 @default.
• W2079585105 cites W2125013140 @default.
• W2079585105 cites W2130945648 @default.
• W2079585105 cites W2132171317 @default.
• W2079585105 cites W2135187257 @default.
• W2079585105 cites W2142614089 @default.
• W2079585105 cites W2163345245 @default.
• W2079585105 cites W2171158272 @default.
• W2079585105 doi "https://doi.org/10.1097/sla.0b013e31821287ac" @default.
• W2079585105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21394015" @default.
• W2079585105 hasPublicationYear "2011" @default.
• W2079585105 type Work @default.
• W2079585105 sameAs 2079585105 @default.
• W2079585105 citedByCount "30" @default.
• W2079585105 countsByYear W20795851052012 @default.
• W2079585105 countsByYear W20795851052013 @default.
• W2079585105 countsByYear W20795851052014 @default.
• W2079585105 countsByYear W20795851052015 @default.
• W2079585105 countsByYear W20795851052016 @default.
• W2079585105 countsByYear W20795851052017 @default.
• W2079585105 countsByYear W20795851052018 @default.
• W2079585105 countsByYear W20795851052019 @default.
• W2079585105 countsByYear W20795851052020 @default.
• W2079585105 countsByYear W20795851052021 @default.
• W2079585105 countsByYear W20795851052022 @default.
• W2079585105 crossrefType "journal-article" @default.
• W2079585105 hasAuthorship W2079585105A5008763534 @default.
• W2079585105 hasAuthorship W2079585105A5028295343 @default.
• W2079585105 hasAuthorship W2079585105A5033931830 @default.
• W2079585105 hasAuthorship W2079585105A5039100454 @default.
• W2079585105 hasAuthorship W2079585105A5057686070 @default.
• W2079585105 hasAuthorship W2079585105A5079072671 @default.
• W2079585105 hasAuthorship W2079585105A5079268091 @default.
• W2079585105 hasConcept C105795698 @default.
• W2079585105 hasConcept C126322002 @default.
• W2079585105 hasConcept C141071460 @default.
• W2079585105 hasConcept C156957248 @default.
• W2079585105 hasConcept C194828623 @default.
• W2079585105 hasConcept C27403532 @default.
• W2079585105 hasConcept C2780868729 @default.
• W2079585105 hasConcept C2991741193 @default.
• W2079585105 hasConcept C33923547 @default.
• W2079585105 hasConcept C71924100 @default.
• W2079585105 hasConcept C77350462 @default.
• W2079585105 hasConceptScore W2079585105C105795698 @default.
• W2079585105 hasConceptScore W2079585105C126322002 @default.
• W2079585105 hasConceptScore W2079585105C141071460 @default.
• W2079585105 hasConceptScore W2079585105C156957248 @default.
• W2079585105 hasConceptScore W2079585105C194828623 @default.
• W2079585105 hasConceptScore W2079585105C27403532 @default.
• W2079585105 hasConceptScore W2079585105C2780868729 @default.
• W2079585105 hasConceptScore W2079585105C2991741193 @default.
• W2079585105 hasConceptScore W2079585105C33923547 @default.
• W2079585105 hasConceptScore W2079585105C71924100 @default.
• W2079585105 hasConceptScore W2079585105C77350462 @default.
• W2079585105 hasIssue "6" @default.
• W2079585105 hasLocation W20795851051 @default.
• W2079585105 hasLocation W20795851052 @default.
• W2079585105 hasOpenAccess W2079585105 @default.
• W2079585105 hasPrimaryLocation W20795851051 @default.
• W2079585105 hasRelatedWork W1574769768 @default.
• W2079585105 hasRelatedWork W1992228662 @default.
• W2079585105 hasRelatedWork W2188664023 @default.
• W2079585105 hasRelatedWork W2481749367 @default.
• W2079585105 hasRelatedWork W2585911331 @default.
• W2079585105 hasRelatedWork W2793477322 @default.

• next